Stay updated on Avelumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Avelumab in NSCLC Clinical Trial page.

Latest updates to the Avelumab in NSCLC Clinical Trial page
- Check4 days agoChange DetectedAdded a footer item 'Revision: v3.3.3' and removed links 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the page footer. These changes are limited to site metadata and do not alter study data, status, or patient-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedThe page history shows an addition of Revision: v3.3.2 and removal of Revision: v3.2.0 from the revision log. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe notice about government funding and operating status was removed; this is an operational change that does not affect the trial data or record status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check54 days agoChange DetectedThe new screenshot shows a revised layout for the Record History page with minor formatting and spacing adjustments, while the underlying version history and study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange Detected- Added a prominent operations status notice about funding and service limitations, and linked official status pages. - Updated version from v3.1.0 to v3.2.0.SummaryDifference11%

- Check90 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.SummaryDifference0.3%

Stay in the know with updates to Avelumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in NSCLC Clinical Trial page.